ArticleJournal of gastrointestinal oncology2021

Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy.

Shane S Neibart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.